A small Brazilian study looking into the efficacy of chloroquine as a treatment for the novel coronavirus was scrapped after some test subjects got severely ill with cardiac issues, and some died, The New York Times reports.
The anti-malaria drug chloroquine and its cousin, hydroxychloroquine, have shown some, limited anecdotal evidence that it’s useful in treating COVID-19, the respiratory illness caused by the virus. Indeed, none other than President Donald Trump has continually touted the drug, often used in combination with the antibiotic azithromycin to treat the disease, and has even called it a “game-changer.”
However, scientists have rejected the idea of using the drug combination to treat COVID-19 based on anecdotal evidence, insisting instead that clinical trials must be conducted under scientifically-rigorous conditions. And though that’s a process that can take months if not years, studies are underway since time is of the essence in the battle against the coronavirus.
0 comments :
Post a Comment